A new bill was introduced on Thursday (June 28) by a leading Democrat in the US Congress seeks to completely decriminalize cannabis.

US Senator Chuck Schumer (D-NY) presented his plan to legalize cannabis across the federal level, unlike the bipartisan bill introduced earlier this month by Senators Elizabeth Warren (D-MA) and Cory Gardner (R-CO), which protected businesses from federal prosecution.

“This legislation is simply the right thing to do and I am hopeful that the balanced approach it takes can earn bipartisan support in Congress and across the country,” Schumer wrote in a statement.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Dubbed the “Marijuana Freedom and Opportunity Act,” this bill will remove cannabis from the list of schedule substances under the Controlled Substances Act (CSA). According to its introduction the bill will still allow the states to decide how to regulate cannabis.

Schumer’s bill will seek to create support grants so local governments can “seal or expunge” cannabis possession conviction records.

A movement of legalization has been gaining momentum throughout the US following an uneasy period of time after Attorney General Jeff Sessions eliminated the Cole memorandum, a government guidance allowing states to dictate their own cannabis law.

Senator Gardner was able agree on a deal with US president Donald Trump, who conceded on allowing the states run their cannabis operations freely. Cannabis has been legalized by nine states both for adult-use and medical, while 29 have legalized it for medical purposes only.

On Monday (June 25) the U.S. Food and Drug Administration (FDA) officially approved Epidiolex, a cannabidiol CBD-based medicine from GW Pharmaceuticals (NASDAQ:GWPH).

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” FDA commissioner Scott Gottlieb said.

Another major moment for the legalization and establishment of the legal cannabis industry came earlier this year when former Speaker of the United States House of Representatives John Boehner joined the board of advisors for Acreage Holdings, a private US-focused cannabis operator.

Investor takeaway

US operators seeking to raise capital in a favorable investor landscape have made the Canadian Securities Exchange (CSE) their home. Thanks to the potential regulations change, investors and analysts are bullish on these stocks.

In a newsletter emailed to subscribers cannabis analyst with 420 Investor Alan Brochstein wrote the “changing of the political winds out of Washington” have allowed a change in how companies and investors “are thinking about risk.”

Barrington Miller, director of listed company services for the CSE told the Investing News Network (INN) the Canadian exchange has seen an increased momentum for cannabis stocks thanks to the changing ways in the US.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less